Isabel Leroux‐Roels

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Jerald Sadoff, Mathieu Le Gars, Georgi Shukarev et al. · New England Journal of Medicine · 2021 · 1.2K citations · Full text

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Alberto Papi, Michael G. Ison, Joanne M. Langley et al. · New England Journal of Medicine · 2023 · 672 citations · Full text

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 500 citations

Vaccination, Cross-protection, Vaccine Development +9

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

Cassandra Aldrich, Isabel Leroux‐Roels, Katell Bidet Huang et al. · Vaccine · 2021 · 195 citations · Full text

Nanoparticles, Nanomedicine, Vaccination +10

Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial

Jan J. De Waele, Sofie Carrette, Mieke Carlier et al. · Intensive Care Medicine · 2013 · 181 citations

Drug Safety, Therapeutic Drug Monitoring, Pharmacological Study +6